Giampaolo Bianchini - Publications, H-index & Citations

Giampaolo Bianchini

IRCCS Ospedale San Raffaele

48H指数

406论文数

1.3W被引数

收录论文 134

发表时间

Low Rates of Discontinuation Unrelated to Disease Progression with Trastuzumab Deruxtecan in Metastatic Breast Cancer: A Real-World Study 曲妥珠单抗德鲁替康在转移性乳腺癌中的停药率低且与疾病进展无关：一项真实世界研究

Cancers

IF4.4

2026-09-07

OAAI

Luca Licata; Francesca Patanè; Alessandra Guarino; Barbara Galbardi; Annarita Battaglia; Marco Mariani; Caterina Zanibelli; Giulia Notini; Matteo Maria Naldini; Carlo Bosi; Antonella Chiavassa; Marta Piras; Irene Persano; Alessia Rognone; Lorenzo Sica; Stefania Zambelli; Patrizia Zucchinelli; Giulia Viale; Giampaolo Bianchini

Netupitant versus aprepitant: model-predicted neurokinin-1 receptor occupancy and implications for long-delayed nausea and vomiting prevention Netupitant与aprepitant的比较：基于模型预测的神经激肽-1受体占有率及其对长效迟发性恶心和呕吐预防的启示

Supportive Care in Cancer

IF3

2026-09-05

OAAI

Hirotoshi Iihara; Giampaolo Bianchini; Matti Aapro; Luca Licata; Alberto Bernareggi; Rudolph M. Navari; Yeon Hee Park; Karin Jordan; María Vidal; Florian Scotté; Eric J. Roeland; Lee Schwartzberg; Hope S. Rugo

Broad baseline-variable profiling of visceral conversion in bone-only HR+/ HER2-metastatic breast cancer treated with CDK4/6 inhibitors 骨转移性HR+/HER2-转移性乳腺癌经CDK4/6抑制剂治疗后腹腔转化的大范围基线-变量分析

European Journal of Cancer

IF7.1

2026-09-01

PREAI

Scafetta, Roberta; Troiano, Raffaella; Guarino, Alessandra; Gullotta, Carla; Fiore, Cristina; Sisca, Luisana; Speziale, Elena; Travisani, Arianna; Zannino, Fernando; Miraglia, Giovanni; Donato, Marco; Foderaro, Simone; Venuti, Fabio; Vilardi, Francesco Antonio; Ricozzi, Valentina; Iuliani, Michele; Simonetti, Sonia; Cavaliere, Silvia; Cortellini, Alessio; La Cesa, Annalisa; Di Mattia, Andrea; Lombardo, Michela; Angelone, Martina; Botticelli, Andrea; Scagnoli, Simone; Pisegna, Simona; Criscitiello, Carmen; Pedersini, Rebecca; Sposetti, Caterina; Tiberi, Elisa; D'Auria, Giuliana; Vergati, Matteo; Mazzotta, Marco; Caputo, Roberta; Verrazzo, Annarita; Rossino, Maria Grazia; Garrone, Ornella; Domati, Federica; Piombino, Claudia; Gatti, Federica; Filomeno, Lorena; Arcuri, Teresa; Puce, Federica; Riva, Federica; Palleschi, Michela; Sirico, Marianna; Piras, Marta; Stucci, Luigia Stefania; De Lisi, Delia; Orsaria, Paolo; Grasso, Antonella; Ippolito, Edy; Ramella, Sara; Visani, Luca; Livi, Lorenzo; Gori, Stefania; Rossi, Luigi; Meattini, Icro; Tagliaferri, Barbara; Caffo, Orazio; Portarena, Ilaria; Irelli, Azzurra; Cretella, Elisabetta; Porta, Camillo; Bianchini, Giampaolo; Fabbri, Maria Agnese; De Giorgi, Ugo; Vici, Patrizia; Toss, Angela; Ruatta, Fiorella; De Laurentiis, Michelino; Villa, Federica; Berardi, Rossana; Minelli, Mauro; Altomare, Vittorio; Vernieri, Claudio; Curigliano, Giuseppe; Chirco, Alessandra; D'Alessandro, Sara; Vincenzi, Bruno; Tonini, Giuseppe; Santini, Daniele; Pantano, Francesco

Time-dependent prognostic impact of tumor grade in stage I-III breast cancers I期-III期乳腺癌中肿瘤分级的时间依赖性预后影响

ESMO Open

IF8.3

2026-08-01

PREAI

Mariani, M.; Ochocki, M.; Bianchini, G.; Marczyk, M.; Pusztai, L.

TroFuse-011 study design: sacituzumab tirumotecan with or without pembrolizumab for advanced triple-negative breast cancer with PD-L1 CPS <10 TroFuse-011研究设计：sacituzumab tirumotecan联合或不联合pembrolizumab治疗PD-L1 CPS<10的晚期三阴性乳腺癌

Future Oncology

IF2.6

2026-07-31

OAAI

Hope S. Rugo; Peter Schmid; Javier Cortes; Toshimi Takano; Peter A. Fasching; Yeon Hee Park; Giampaolo Bianchini; Sandra Ximena Franco; Cynthia Villarreal-Garza; Olivier Tredan; Yongmei Yin; Romualdo Barroso-Sousa; Xuan Peng; Usha Malhotra; Karen Lisa Smith; Aditya Bardia

SERENA-6 visual patient-reported outcomes and safety: camizestrant for emerging ESR1m advanced breast cancer during first-line endocrine-based therapy SERENA-6视觉患者报告结局与安全性：卡米昔司rant用于新发ESR1m晚期乳腺癌的一线内分泌治疗

Oncologist

IF4.2

2026-07-24

OAAI

Adam Brufsky, MD; Yeon Hee Park, MD; François-Clément Bidard, MD; Erica L Mayer, MD; Wolfgang Janni, MD; Cynthia Ma, MD; Massimo Cristofanilli, MD; Giampaolo Bianchini, MD; Hiroji Iwata, MD; Peter A Fasching, MD; Zbigniew Nowecki, MD; Javier Pascual, MD; Shin-Cheh Chen, MD; Lionel Moreau, MD; Manuel Ruiz-Borrego, MD; Ayelet Shai, MD; Nuri Karadurmus, MD; Kyung Hae Jung, MD; Yuichiro Kikawa, MD; Richard D Baird, MD; Ranya Habash, MD; Rebecca Sugarman, MSc; Steven Fox, MSc; Manuel Selvi Miralles, MD; Cynthia Huang Bartlett, MD; Nicholas Turner, MD; null

Switching to camizestrant at ESR1 mutation emergence before disease progression during first-line treatment of hormone receptor-positive advanced breast cancer (SERENA-6): extended analysis of a double-blind, placebo-controlled, randomised, phase 3 trial 在激素受体阳性晚期乳腺癌一线治疗期间，于ESR1突变出现但疾病进展前转换至卡米泽斯特rant（SERENA-6）：一项双盲、安慰剂对照、随机III期试验的扩展分析

Lancet Oncology

IF35.9

2026-07-13

PREAI

Nicholas C Turner; Erica L Mayer; Yeon Hee Park; Wolfgang Janni; Cynthia Ma; Massimo Cristofanilli; Giampaolo Bianchini; Kevin Kalinsky; Hiroji Iwata; Stephen Chia; Adam M Brufsky; Peter A Fasching; Zbigniew Nowecki; Javier Pascual; Nuri Karadurmus; Einav Gal-Yam; Wei-Pang Chung; Seock-Ah Im; Alberto Zambelli; Florence Dalenc

[18F]FDG PET/MRI for axillary staging in node positive breast cancer patients receiving primary systemic therapy. A prospective single arm trial [18F]FDG PET/MRI在淋巴结阳性乳腺癌患者接受新辅助系统性治疗后的腋窝分期中的应用：一项前瞻性单臂试验

Breast

IF7.9

2026-07-01

PREAI

Di Micco, Rosa; Botteri, Edoardo; Canevari, Carla; Gallivanone, Francesca; Antunovic, Lidjia; Scifo, Paola; Neri, Ilaria; Gelardi, Fabrizia; Magnani, Patrizia; Losio, Claudio; Venturini, Elena; Della Vecchia, Giovanna; Ferrarese, Goffredo; Rotmensz, Nicole; Zuber, Veronica; Baleri, Sara; Cisternino, Giovanni; Calabretto, Francesca; Corona, Silvia P.; Rampa, Mario; Hammami, Dema Wahid S.; Scaduto, Vitalba; Morgante, Manuela M.; Viale, Giulia; Piras, Marta; Licata, Luca; Sassi, Isabella; Bianchini, Giampaolo; Panizza, Pietro; Chiti, Arturo; Gentilini, Oreste D.

The role of the 21-gene assay in the neoadjuvant setting for hormone receptor-positive HER2-negative breast cancer: Impact on systemic and surgical treatment decisions 21基因检测在激素受体阳性HER2阴性乳腺癌新辅助治疗中的作用：对系统性治疗和手术治疗决策的影响

Cancer Treatment Reviews

IF10.5

2026-05-27

OAAI

Á.Guerrero Zotano; T.M. Allweis; R. Foerster; C. Palmieri; O. Gluz; S. Chia; C. Sotiriou; G. Bianchini

Integrating PIK3CA Testing into Clinical Practice for Advanced HR+/HER2- Breast Cancer: An Expert Consensus 将PIK3CA检测整合到晚期HR+/HER2-乳腺癌临床实践中的专家共识

The Breast

IF0

2026-04-10

OAAI

Carmine De Angelis; Dario de Biase; Lorenzo Gerratana; Grazia Arpino; Giampaolo Bianchini; Isabella Castellano; Giuseppe Curigliano; Lucia Del Mastro; Alessandra Fabi; Nicola Fusco; Alessandra Gennari; Valentina Guarneri; Claudio Zamagni; Alberto Zambelli; Umberto Malapelle; Fabio Puglisi

Characterization of the safety profile of trastuzumab deruxtecan by dose: a pooled analysis across DESTINY studies 根据剂量对曲妥珠单抗德鲁替康的安全性特征进行表征：一项跨越DESTINY研究的合并分析

ONCOLOGIST

IF4.2

2026-01-01

PREAI

Park, Yeon Hee; Cortes, Javier; Modi, Shanu; Hurvitz, Sara A.; Bianchini, Giampaolo; Iwata, Hiroji; Shitara, Kohei; Siena, Salvatore; Goto, Yasushi; Ku, Geoffrey Y.; Powell, Charles A.; Swain, Sandra M.; Arunachalam, Meena; Janek, Martin; Cheng, Yingkai; Chu, Changan; Verma, Purnima; Kuptsova-Clarkson, Nataliya; Mathias, Elton; Goodman, Erin; Rugo, Hope S.

European experience of patients with HER2-positive advanced/metastatic breast cancer accessing trastuzumab deruxtecan through a named patient program: the EUROPA T-DXd study HER2阳性晚期/转移性乳腺癌患者通过指定患者计划获取曲妥珠单抗德鲁替康的欧洲经验：EUROPA T-DXd研究

Frontiers in Oncology

IF3.3

2025-10-14

OAAI

Cristina Saura; Hans Wildiers; Giampaolo Bianchini; José Ángel García-Saenz; Arthur Allignol; Amanda Logue; Markus Lucerna; Sabine Stamenitis; Michelino De Laurentiis

Tumor-specific major histocompatibility-II expression predicts pathological complete response to atezolizumab combined to chemotherapy in triple-negative breast cancer 肿瘤特异性主要组织相容性-II表达预测三阴性乳腺癌中阿替利珠单抗联合化疗的病理完全缓解

npj Breast Cancer

IF7.6

2025-09-29

OAAI

Justin M. Balko; Luca Licata; Xiao Qian Wang; Matteo Dugo; Chiun-Sheng Huang; Daniel Egle; Begoña Bermejo; Claudio Zamagni; Marc Thill; Antonio Anton; Stefania Russo; Elena Sevillano; Eva Maria Ciruelos; Richard Greil; Vladimir Semiglazov; Marco Colleoni; Catherine M. Kelly; Gabriella Mariani; Lucia Del Mastro; Stefania Zambelli; Giulia Viale; Maurizio Callari; Giuseppe Viale; Lajos Pusztai; Luca Gianni; H. Raza Ali; Giampaolo Bianchini

Management of trastuzumab deruxtecan-related adverse events in breast cancer: Italian expert panel recommendations 曲妥珠单抗德鲁克替康相关不良反应在乳腺癌中的管理：意大利专家小组建议

Future Oncology

IF2.6

2025-07-23

OAAI

Giampaolo Bianchini; Alessandra Fabi; Valentina Guarneri; Grazia Arpino; Michelino De Laurentis; Alberto Zambelli; Claudio Zamagni; Laura Biganzoli; Fabio Puglisi; Daniele Santini

PCSK9 expression and cancer survival: a prognostic biomarker at the intersection of oncology and geroscience PCSK9表达与癌症生存：一个位于肿瘤学与老年学交叉点的预后生物标志物

GeroScience

IF5.4

2025-06-27

OAAI

Zoltan Ungvari; Otília Menyhart; Andrea Lehoczki; Monika Fekete; Giampaolo Bianchini; Balázs Győrffy

Overcoming Resistance to CDK4/6 inhibitors in Hormone Receptor positive, HER2 negative breast cancer: Innovative Combinations and Emerging Strategies 克服激素受体阳性、HER2阴性乳腺癌对CDK4/6抑制剂的耐药性：创新联合疗法与新兴策略

Cancer Treatment Reviews

IF10.5

2025-06-14

OAAI

Federica Giugliano; Carmine De Angelis; Barbara Pistilli; Giulia Viale; Giampaolo Bianchini; Mario Giuliano; Luca Malorni; Beatrice Taurelli Salimbeni; Angela Esposito; Antonio Giordano; Timothy A. Yap; Giuseppe Curigliano; Carmen Criscitiello

The evolving landscape of hormone receptor-positive/HER2-negative metastatic breast cancer (EVOLVE): An Italian Delphi consensus report 激素受体阳性/HER2阴性转移性乳腺癌的演变格局（EVOLVE）：一项意大利Delphi共识报告

critical reviews in oncology hematology

IF0

2025-06-06

OAAI

Federica Miglietta; Maria Grazia Razeti; Aldo Caltavituro; Arianna Dri; Carmine Valenza; Giampaolo Bianchini; Laura Biganzoli; Andrea Botticelli; Michele Caruso; Saverio Cinieri; Carmen Criscitiello; Carmine De Angelis; Michelino De Laurentis; Lucia Del Mastro; Sabino De Placido; Marzia Del Re; Maria Vittoria Dieci; Alessandra Fabi; Daniele Generali; Alessandra Gennari; Grazia Arpino

Delphi consensus on the management of adverse events in patients with metastatic triple-negative breast cancer treated with sacituzumab govitecan 沙芬戈曲普坦治疗转移性三阴性乳腺癌患者不良反应管理的德尔菲共识

ONCOLOGIST

IF4.2

2025-05-14

OAAI

Valsecchi, Anna Amela; Pisegna, Simona; Antonuzzo, Andrea; Arpino, Grazia; Bianchini, Giampaolo; Biganzoli, Laura; Colloca, Giuseppe Ferdinando; Criscitiello, Carmen; Danesi, Romano; Fabi, Alessandra; Giusti, Raffaele; Pau, Loredana; Santini, Daniele

Unlocking the power of immune checkpoint inhibitors: Targeting YAP1 reduces anti-PD1 resistance in skin cutaneous melanoma 解锁免疫检查点抑制剂的潜力：靶向YAP1可降低皮肤黑色素瘤对抗PD1的耐药性

British Journal of Pharmacology

IF7.7

2025-05-05

OAAI

Szonja Anna Kovács; Tamás Kovács; András Lánczky; Ágnes Paál; Zsombor I. Hegedűs; Nabil V. Sayour; Lilla Szabó; Andrea Kovács; Giampaolo Bianchini

Melanoma Proteomics Unveiled: Harmonizing Diverse Data Sets for Biomarker Discovery and Clinical Insights via MEL-PLOT 黑色素瘤蛋白质组学解析：通过MEL-PLOT协调多样化数据集以发现生物标志物并获得临床洞见

JOURNAL OF PROTEOME RESEARCH

IF3.6

2025-05-05

OAAI

Bartha, Aron; Weltz, Boglarka; Betancourt, Lazaro Hiram; Gil, Jeovanis; de Almeida, Natalia Pinto; Bianchini, Giampaolo; Szeitz, Beata; Szadai, Leticia; Pla, Indira; Kemeny, Lajos; Janosi, Agnes Judit; Hong, Runyu; Rajeh, Ahmad; Nogueira, Fabio; Doma, Viktoria; Woldmar, Nicole; Guedes, Jessica; Ujfaludi, Zsuzsanna; Kim, Yonghyo; Szarvas, Tibor; Pahi, Zoltan; Pankotai, Tibor; Szasz, A. Marcell; Sanchez, Aniel; Baldetorp, Bo; Timar, Jozsef; Nemeth, IstvanBalazs; Karpati, Sarolta; Appelqvist, Roger; Domont, Gilberto Barbosa; Pawlowski, Krzysztof; Wieslander, Elisabet; Malm, Johan; Fenyo, David; Horvatovich, Peter; Marko-Varga, Gyorgy; Gyorffy, Balazs

研究方向